Publications (58)

2018

  1. Direct medical costs and their predictors in the EMAR-II cohort: “Variability in the management of rheumatoid arthritis and spondyloarthritis in Spain”

    Reumatologia Clinica, Vol. 14, Núm. 1, pp. 4-8

2013

  1. Orthopedic surgery in rheumatoid arthritis in the era of biologic therapy

    Journal of Rheumatology, Vol. 40, Núm. 11, pp. 1850-1855

2011

  1. Información incluida en la ficha técnica de los radiofármacos de uso humano autorizados para comercialización en España

    Revista española de medicina nuclear, Vol. 30, Núm. 1, pp. 41-46

2010

  1. Medicamentos genéricos: evidencias y mitos

    Información terapéutica del Sistema Nacional de Salud, Vol. 34, Núm. 3, pp. 71-82

2009

  1. Uso de fármacos modificadores de la enfermedad en artritis reumatoide

    Información terapéutica del Sistema Nacional de Salud, Vol. 33, Núm. 4, pp. 99-109

  2. Treatment of refractory posterior uveitis with infliximab: A 7-year follow-up study

    Scandinavian Journal of Rheumatology, Vol. 38, Núm. 1, pp. 58-62

2008

  1. Medición de la actividad en la espondilitis anquilosante

    Seminarios de la Fundacion Espanola de Reumatologia, Vol. 9, Núm. 1, pp. 59-66

  2. Prognostic factors in short-term disability due to musculoskeletal disorders

    Arthritis Care and Research, Vol. 59, Núm. 4, pp. 489-496

  3. Observed and expected frequency of comorbid chronic diseases in rheumatic patients

    Annals of the Rheumatic Diseases, Vol. 67, Núm. 3, pp. 418-421

  4. Medición de la actividad en la espondilitis anquilosante

    Seminarios de la Fundación Española de Reumatología, Vol. 9, Núm. 1, pp. 59-66

  5. Differences between rheumatology attending physicians and training residents in the management of rheumatoid arthritis in Spain

    Scandinavian Journal of Rheumatology, Vol. 37, Núm. 6, pp. 419-426

  6. Burden of disease across chronic diseases: A health survey that measured prevalence, function, and quality of life

    Journal of Rheumatology, Vol. 35, Núm. 1, pp. 159-165

2007

  1. Variability in the use of orthopedic surgery in patients with rheumatoid arthritis in Spain

    Journal of Rheumatology, Vol. 34, Núm. 7, pp. 1485-1490

  2. Musculoskeletal work disability for clinicians: Time course and effectiveness of a specialized intervention program by diagnosis

    Arthritis Care and Research, Vol. 57, Núm. 2, pp. 335-342

  3. Human parvovirus B19, varicella zoster virus, and human herpesvirus-6 in mesenchymal stem cells of patients with osteoarthritis: analysis with quantitative real-time polymerase chain reaction

    Osteoarthritis and Cartilage, Vol. 15, Núm. 4, pp. 475-478

  4. Disminución del tiempo hasta el primer tratamiento con fármacos modificadores de la enfermedad en pacientes con artritis reumatoide

    Reumatologia Clinica, Vol. 3, Núm. 6, pp. 245-250

  5. Adjunctive methotrexate for treatment of giant cell arteritis: An individual patient data meta-analysis

    Arthritis and Rheumatism, Vol. 56, Núm. 8, pp. 2789-2797

2005

  1. A health system program to reduce work disability related to musculoskeletal disorders

    Annals of Internal Medicine, Vol. 143, Núm. 6

2003

  1. Disparate results in studies of methotrexate plus corticosteroids in the treatment of giant cell arteritis: Comment on the article by Hoffman et al [1]

    Arthritis and Rheumatism

  2. Costs and predictors of costs in rheumatoid arthritis: A prevalence-based study

    Arthritis Care and Research, Vol. 49, Núm. 1, pp. 64-70